☰

Siddhant Jain - Publications

Affiliations: 
2013-2020 University of Wisconsin, Madison, Madison, WI 
Tree Info Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Jain SU, Khazaei S, Marchione DM, Lundgren SM, Wang X, Weinberg DN, Deshmukh S, Juretic N, Lu C, Allis CD, Garcia BA, Jabado N, Lewis PW. Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression. Proceedings of the National Academy of Sciences of the United States of America. PMID 33067396 DOI: 10.1073/pnas.2006076117  0.808
2020 Jain SU, Rashoff AQ, Krabbenhoft SD, Hoelper D, Do TJ, Gibson TJ, Lundgren SM, Bondra ER, Deshmukh S, Harutyunyan AS, Juretic N, Jabado N, Harrison MM, Lewis PW. H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2. Molecular Cell. PMID 33049227 DOI: 10.1016/j.molcel.2020.09.028  0.646
2020 Khazaei S, De Jay N, Deshmukh S, Hendrikse LD, Jawhar W, Chen CC, Mikael LG, Faury D, Marchione DM, Lanoix J, Bonneil E, Ishii T, Jain SU, Rossokhata K, Sihota TS, et al. H3.3G34W promotes growth and impedes differentiation of osteoblast-like mesenchymal progenitors in Giant Cell Tumour of Bone. Cancer Discovery. PMID 32967858 DOI: 10.1158/2159-8290.CD-20-0461  0.684
2019 Jain SU, Do TJ, Lund PJ, Rashoff AQ, Diehl KL, Cieslik M, Bajic A, Juretic N, Deshmukh S, Venneti S, Muir TW, Garcia BA, Jabado N, Lewis PW. PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism. Nature Communications. 10: 2146. PMID 31086175 DOI: 10.1038/S41467-019-09981-6  0.708
2019 Jani KS, Jain SU, Ge EJ, Diehl KL, Lundgren SM, Müller MM, Lewis PW, Muir TW. Histone H3 tail binds a unique sensing pocket in EZH2 to activate the PRC2 methyltransferase. Proceedings of the National Academy of Sciences of the United States of America. PMID 30967505 DOI: 10.1073/Pnas.1819029116  0.736
2019 Harutyunyan AS, Krug B, Chen H, Papillon-Cavanagh S, Zeinieh M, De Jay N, Deshmukh S, Chen CCL, Belle J, Mikael LG, Marchione DM, Li R, Nikbakht H, Hu B, Cagnone G, ... ... Jain SU, et al. H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis. Nature Communications. 10: 1262. PMID 30890717 DOI: 10.1038/S41467-019-09140-X  0.683
2019 McDaniel SL, Gibson TJ, Schulz KN, Fernandez Garcia M, Nevil M, Jain SU, Lewis PW, Zaret KS, Harrison MM. Continued Activity of the Pioneer Factor Zelda Is Required to Drive Zygotic Genome Activation. Molecular Cell. PMID 30797686 DOI: 10.1016/J.Molcel.2019.01.014  0.543
2018 Lu C, Jain S, Hoelper D, Bechet D, Ran L, Andrulis I, Dickson B, Majewski J, Thompson C, Chi P, Garcia B, Jabado N, Lewis P, Allis CD. Abstract PR12: Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-Pr12  0.806
2017 Venneti S, Bayliss J, Mukherjee P, Lu C, Jain S, Chung C, Martinez D, Sabari B, Margol A, Panwalkar P, Paroloia A, Pekmezci M, Eachin RM, Cieslik M, Tamrazi B, et al. Abstract 3863: A subset of poorly prognostic pediatric posterior fossa ependymomas exhibit lowered H3K27me3 and DNA hypomethylation and show epigenetic similarities with H3K27M mutant diffuse intrinsic pontine gliomas Cancer Research. 77: 3863-3863. DOI: 10.1158/1538-7445.Am2017-3863  0.733
2017 Venneti S, Bayliss J, Mukherjee P, Lu C, Jain S, Chung C, Panwalkar P, Martinez D, Sabari B, Margol A, Pekmezci M, Cieslik M, Tamrazi B, Garcia B, Santi M, et al. EPND-08. EPIGENETIC H3K27ME3 DEREGULATION IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMAS Neuro-Oncology. 19: iv16-iv17. DOI: 10.1093/Neuonc/Nox083.066  0.659
2016 Bayliss J, Mukherjee P, Lu C, Jain SU, Chung C, Martinez D, Sabari B, Margol AS, Panwalkar P, Parolia A, Pekmezci M, McEachin RC, Cieslik M, Tamrazi B, Garcia BA, et al. Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas. Science Translational Medicine. 8: 366ra161. PMID 27881822 DOI: 10.1126/Scitranslmed.Aah6904  0.623
2016 Jayaram H, Hoelper D, Jain SU, Cantone N, Lundgren SM, Poy F, Allis CD, Cummings R, Bellon S, Lewis PW. S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3. Proceedings of the National Academy of Sciences of the United States of America. PMID 27185940 DOI: 10.1073/Pnas.1605523113  0.793
2016 Lu C, Jain SU, Hoelper D, Bechet D, Molden RC, Ran L, Murphy D, Venneti S, Hameed M, Pawel BR, Wunder JS, Dickson BC, Lundgren SM, Jani KS, De Jay N, et al. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape. Science (New York, N.Y.). 352: 844-9. PMID 27174990 DOI: 10.1126/Science.Aac7272  0.811
2016 Venneti S, Bayliss J, Mukherjee P, Lu C, Jain S, Martinez D, Margol A, Pekmezci M, Chung C, Eachin RM, Cieslik M, Garcia B, Tamrazi B, Larocca G, Santi M, et al. GENT-44. LOWERED H3K27me3 AND DNA HYPOMETHYLATION DEFINE POORLY PROGNOSTIC PEDIATRIC POSTERIOR FOSSA EPENDYMOMAS Neuro-Oncology. 18: vi83-vi84. DOI: 10.1093/Neuonc/Now212.350  0.626
2014 Brown ZZ, Müller MM, Jain SU, Allis CD, Lewis PW, Muir TW. Strategy for "detoxification" of a cancer-derived histone mutant based on mapping its interaction with the methyltransferase PRC2. Journal of the American Chemical Society. 136: 13498-501. PMID 25180930 DOI: 10.1021/Ja5060934  0.781
Show low-probability matches.